Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ESSA Pharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
EPIX
Nasdaq
8731
https://www.essapharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ESSA Pharma Inc
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
- Apr 9th, 2024 12:00 pm
ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
- Apr 8th, 2024 4:00 pm
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
- Mar 8th, 2024 1:13 am
12 $10 Stocks That Will Triple
- Feb 26th, 2024 6:14 pm
EPIX: Risk Profile of Patients in Phase 1/2 Trial of Masofaniten Reveals Majority at High Risk for Early Enzalutamide Failure…
- Feb 16th, 2024 12:28 pm
ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results
- Feb 14th, 2024 9:35 am
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023
- Feb 13th, 2024 12:00 pm
ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares
- Feb 8th, 2024 1:47 am
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 6th, 2024 1:00 pm
EPIX: Updated Data for Phase 1 Trial of Masofaniten Shows 63% of Patients Achieved PSA <0.2 ng/mL…
- Jan 26th, 2024 10:36 am
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
- Jan 25th, 2024 3:00 pm
ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains
- Jan 22nd, 2024 12:16 pm
These Stocks under $10 Are Poised To Explode
- Dec 21st, 2023 9:13 pm
EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…
- Dec 20th, 2023 1:23 pm
ESSA Pharma Inc (EPIX) Reports Fiscal Q4 and Full-Year Earnings, Advances in Prostate Cancer ...
- Dec 12th, 2023 2:12 pm
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023
- Dec 12th, 2023 12:00 pm
Bullish ESSA Pharma Insiders Loaded Up On US$1.19m Of Stock
- Dec 11th, 2023 10:17 am
Director Franklin Berger Bolsters Position in ESSA Pharma Inc with Purchase of 23,259 Shares
- Nov 23rd, 2023 4:05 pm
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference
- Nov 21st, 2023 1:00 pm
ESSA Pharma to Present at the Jefferies London Healthcare Conference
- Nov 8th, 2023 1:00 pm
Scroll